PMED
PMED

Predictmedix AI Inc.

Status
Active
Issued & Outstanding150,259,542
Reserved for Issuance31,217,150
Currency
CSE Index

About

Predictmedix AI Inc.

Listing date
December 20, 2019
Social

Predictmedix AI Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry.  Predictmedix is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease.